DRI Healthcare Trust (TSE:DHT.UN) Given New C$22.00 Price Target at Stifel Nicolaus

DRI Healthcare Trust (TSE:DHT.UN) had its price target hoisted by investment analysts at Stifel Nicolaus from C$21.00 to C$22.00 in a report issued on Thursday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price target would indicate a potential upside of 33.50% from the stock’s previous close.

DRI Healthcare Trust Stock Performance

DHT.UN stock traded down C$0.18 during midday trading on Thursday, hitting C$16.48. 4,279 shares of the stock were exchanged, compared to its average volume of 35,068. The stock’s 50-day moving average price is C$16.50 and its 200-day moving average price is C$15.91. The stock has a market cap of C$907.62 million, a price-to-earnings ratio of -18.11 and a beta of 0.41. DRI Healthcare Trust has a fifty-two week low of C$10.70 and a fifty-two week high of C$17.69.

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.